UB Paderborn / Katalog / Suche / in CDI

Causal analyses with target trial emulation for real-world evidence removed large self-inflicted biases: systematic bias assessment of ovarian cancer treatment effectiveness

Journal of clinical epidemiology, 2022-12, Vol.152, p.269-280

2022

Link zum Volltext

Verfügbarkeit prüfen

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer

BMC cancer, 2016-02, Vol.16 (103), p.102-102, Article 102

2016

Link zum Volltext

Verfügbarkeit prüfen

21/#810 A current perspective on endometrial carcinoma (EC) risk classification: results from an European multicentre initiative

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A35-A35

2022

Link zum Volltext

Verfügbarkeit prüfen

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium

Frontiers in oncology, 2019-09, Vol.9, p.832-832

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers

BMC cancer, 2016-08, Vol.16 (1), p.589-589, Article 589

2016

Link zum Volltext

Verfügbarkeit prüfen

L1CAM in the Early Enteric and Urogenital System

The journal of histochemistry and cytochemistry, 2017-01, Vol.65 (1), p.21-32

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of RANK Signalling in Ovarian Cancer

Cancers, 2019-06, Vol.11 (6), p.791

2019

Link zum Volltext

Verfügbarkeit prüfen

Activated p38-MAPK and Gemcitabine Sensitivity in Recurrent Ovarian Cancer

Anticancer research, 2008-09, Vol.28 (5B), p.2975-2980

2008

Link zum Volltext

Verfügbarkeit prüfen

NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer

Tumor biology, 2019-02, Vol.41 (2), p.1010428319830002-v45

2019

Link zum Volltext

Verfügbarkeit prüfen

Interactions of Human Peritoneal Mesothelial Cells With Serous Ovarian Cancer Cell Spheroids—Evidence for a Mechanical and Paracrine Barrier Function of the Peritoneal Mesothelium

International journal of gynecological cancer, 2014-02, Vol.24 (2), p.192-200

2014

Link zum Volltext

Verfügbarkeit prüfen

Epithelial growth factor receptor status in primary and recurrent ovarian cancer

Modern pathology, 2006-04, Vol.19 (4), p.607-610

2006

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement

Wiener medizinische Wochenschrift, 2015-10, Vol.165 (19-20), p.387-394

2015

Link zum Volltext

Verfügbarkeit prüfen

Antibody–drug conjugates in ovarian cancer

Memo - Magazine of European medical oncology, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer

Gynecologic oncology, 2023-03, Vol.170, p.290-299

2023

Link zum Volltext

Verfügbarkeit prüfen

Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) – Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care

Geburtshilfe und Frauenheilkunde, 2023-08, Vol.83 (8), p.963-995

2023

Link zum Volltext

Verfügbarkeit prüfen

Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures

Geburtshilfe und Frauenheilkunde, 2023-08, Vol.83 (8), p.919-962

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR

Oncotarget, 2016-06, Vol.7 (26), p.40221-40232

2016

Link zum Volltext

Verfügbarkeit prüfen

REGULATION OF TRANSFORMING GROWTH FACTOR-β SECRETION BY HUMAN PERITONEAL MESOTHELIAL AND OVARIAN CARCINOMA CELLS

Cytokine (Philadelphia, Pa.), 2000-07, Vol.12 (7), p.1115-1119

2000

Link zum Volltext

Verfügbarkeit prüfen

Disruption of the integrity of human peritoneal mesothelium by interleukin-1? and tumor necrosis factor-?

Virchows Archiv : an international journal of pathology, 2003-11, Vol.443 (5), p.678-685

2003

Link zum Volltext

Verfügbarkeit prüfen

Preserved Coupling of Oxidative Phosphorylation But Decreased Mitochondrial Respiratory Capacity in IL-1β-Treated Human Peritoneal Mesothelial Cells

Cell biochemistry and biophysics, 2006-01, Vol.44 (2), p.179-186

2006

Link zum Volltext

Verfügbarkeit prüfen

Basic Fibroblast Growth Factor Synthesis by Human Peritoneal Mesothelial Cells

The American journal of pathology, 1999-12, Vol.155 (6), p.1977-1984

1999

Link zum Volltext

Verfügbarkeit prüfen

Ovarian carcinoma cells and IL-1β-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions

Gynecologic oncology, 2005-06, Vol.97 (3), p.784-789

2005

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer

Wiener Klinische Wochenschrift, 2012-09, Vol.124 (17-18), p.669-669

2012

Link zum Volltext

Verfügbarkeit prüfen

Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer

Wiener Klinische Wochenschrift, 2012-06, Vol.124 (11-12), p.412-418

2012

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Causal analyses with target trial emulation for real-world evidence removed large self-inflicted biases: systematic bias assessment of ovarian cancer treatment effectiveness

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer

21/#810 A current perspective on endometrial carcinoma (EC) risk classification: results from an European multicentre initiative

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers

L1CAM in the Early Enteric and Urogenital System

Clinical Impact of RANK Signalling in Ovarian Cancer

Activated p38-MAPK and Gemcitabine Sensitivity in Recurrent Ovarian Cancer

NADPH oxidase 4 expression in the normal endometrium and in endometrial cancer

Interactions of Human Peritoneal Mesothelial Cells With Serous Ovarian Cancer Cell Spheroids—Evidence for a Mechanical and Paracrine Barrier Function of the Peritoneal Mesothelium

Epithelial growth factor receptor status in primary and recurrent ovarian cancer

Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement

Antibody–drug conjugates in ovarian cancer

An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer

Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures

Expression III: patients’ expectations and preferences regarding physician–patient relationship and clinical management—results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR

REGULATION OF TRANSFORMING GROWTH FACTOR-β SECRETION BY HUMAN PERITONEAL MESOTHELIAL AND OVARIAN CARCINOMA CELLS

Disruption of the integrity of human peritoneal mesothelium by interleukin-1? and tumor necrosis factor-?

Preserved Coupling of Oxidative Phosphorylation But Decreased Mitochondrial Respiratory Capacity in IL-1β-Treated Human Peritoneal Mesothelial Cells

Basic Fibroblast Growth Factor Synthesis by Human Peritoneal Mesothelial Cells

Ovarian carcinoma cells and IL-1β-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions

Erratum to: Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer

Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer

Suchergebnisse filtern